Monthly Archives - July 2020

Myomo launches MyoCare

Myomo announced today that it launched its MyoCare program for providing support to first-year users of its MyoPro powered brace.MyoCare offers expanded support to current and future clients who receive their MyoPro directly from the Cambridge, Mass.-based company, at no additional cost. Read more >>

Pittsburgh biotech company wins funding for Covid-19 drug

Pittsburgh biotech company CytoAgents has received $250,000 from the Richard King Mellon Foundation to help develop its drug candidate to treat cytokine storm, a deadly complication of Covid-19 and other upper respiratory illnesses. CytoAgents has been working on phase I and phase II clinical trials for GP1681, its existing drug candidate that even before Covid-19 had treated the immune response that causes inflammation and respiratory distress for people with severe influenza. It received a $1.6 million grant from the […]

LaunchPad Medical Initiates its First European Clinical Study

LaunchPad Medical, Inc. announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study to examine the safety and efficacy of Tetranite®, the company’s bone adhesive biomaterial, to immediately stabilize dental implants following tooth extractions. Read more >>

Employers Boost Use Of Digital Tools To Stamp Out Student Debt

The student debt crisis is something of a ticking time bomb, and employers are increasingly stepping up by offering digital tools to help diffuse the problem. A growing number of employers are partnering with digital platforms—such as BenefitEd, Goodly, E*TRADE’s Gradifi, FutureFuel.io, IonTuition, PayForED, Savi, Summer and Vault to name a few—to help provide student debt relief to employees. Read more >>

Research Finds MyoPro® Delivers Meaningful Improvements in Motor Function for Brain Injury Patient

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that new published research measuring the benefits of the Company’s MyoPro myoelectric orthosis found “Despite long-standing traumatic brain injury, meaningful improvements in motor function were observed.” Read more >>